MEDITECH(SH:603990) Sou Hu Cai Jing·2025-06-28 18:19Core Viewpoint - The company, Madi Technology, is experiencing growth in its core business of medical information technology, focusing on expanding its scale and upgrading its structure, with significant long-term growth potential in the healthcare IT sector [1][3]. Group 1: Company Performance - As of June 27, 2025, Madi Technology's stock closed at 16.1 yuan, a 5.92% increase from the previous week, with a market capitalization of 4.931 billion yuan [1]. - The company’s core products, DoCare and DoRicon, are utilized in over 2,400 medical institutions across China, including nearly 1,200 tertiary hospitals [1]. Group 2: Business Development - Madi Technology is focusing on the development of a "software platform + smart hardware + algorithm engine" product system, targeting areas such as smart surgery and emergency rescue [1][2]. - The company has established an innovation department to focus on new business development, reallocating 43.5479 million yuan of previously raised funds for the "Innovation Product R&D Center Project" [2]. Group 3: Industry Trends - The healthcare IT spending in China is projected to reach 84.57 billion yuan by 2025, indicating a high growth phase for the industry [1]. - The company is positioning itself as a supplier of comprehensive smart healthcare solutions and is actively participating in pilot projects and the construction of smart healthcare platforms [4]. Group 4: Strategic Initiatives - Madi Technology is committed to building a data asset operation platform, exploring a closed-loop path from data collection to data assetization [3]. - The company is enhancing its clinical information systems and emergency rescue capabilities by integrating AI technologies to support decision-making and data management [3][4]. Group 5: Financial Management - The company has completed the implementation of several fundraising projects and has established new agreements for the management of raised funds to protect investor rights [5].